Key result
Percutaneous PFO closure resolves platypnea and improves hypoxemia in Platypnea-Orthodeoxia Syndrome.
Case Report (n=1)
Percutaneous device closure of a patent foramen ovale can successfully treat Platypnea-Orthodeoxia Syndrome by eliminating the right-to-left intracardiac shunt.
Answers are grounded in this paper and cite their sources.
May support PFO closure in platypnea-orthodeoxia syndrome; leaves open need for prospective validation.
BACKGROUND Patent Foramen Ovale (PFO) is an important part of fetal circulation. It allows the oxygenated blood from the umbilical cord to bypass the lungs. PFOs usually close after birth due to the sudden change of the hemodynamics associated with the expansion of the lungs however they are known to persist in about 25% of the total population. One of their rare manifestations is Platypnea-Orthodeoxia Syndrome (POS) that presents as dyspnea upon assuming an upright position, which improves upon recumbency, accompanied by hypoxemia. CASE REPORT We report a case of a 63-year-old man, known to have systemic lupus erythematosus (SLE) and positive anti-phospholipid antibodies but with no prior thrombotic events, admitted with symptoms of SARS-COV2 infection, and developed symptoms of Platypnea-Orthodeoxia Syndrome during his hospitalization, further evaluation by a transthoracic echocardiography revealed he had PFO with a right-to-left shunt which was treated successfully with percutaneous device closure. CONCLUSIONS Platypnea-Orthodeoxia Syndrome (POS) can be associated with various cardiac defects resulting in right-to-left shunts and other non-cardiac pathologies such as pulmonary AV malformations, lung parenchymal diseases and hepatopulmonary syndrome. In cases of cardiac right-to-left shunts Contrast-enhanced Transthoracic Echocardiography (TTE) can effectively diagnose Platypnea-Orthodeoxia Syndrome, and percutaneous closure has shown to be an efficacious treatment option in alleviating the symptoms. This case report highlights the necessity of actively exploring the possibility of PFOs with right-to-left shunts in patients exhibiting POS symptoms, while considering other potential aetiologies.
No takes yet. Share an insight, caveat, or question.
Saadi et al. (2023) conducted a case report in Platypnea-Orthodeoxia Syndrome with Patent Foramen Ovale (n=1). Percutaneous device closure (Amplatzer 25-mm PFO device) was evaluated on Resolution of platypnea and improvement in oxygen requirements. Percutaneous device closure of a patent foramen ovale successfully resolved platypnea and improved oxygen requirements in a patient with Platypnea-Orthodeoxia Syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: